$0.02
(Market cap
$18 Mln
Revenue (TTM)
$268 Mln
P/E Ratio
--
P/B Ratio
3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-615 Mln
-
ROE
-5.3 %
-
ROCE
-- %
-
Industry P/E
530.85
-
EV/EBITDA
-4.7
-
Debt to Equity
-1
-
Book Value
$--
-
EPS
$-1.8
-
Face value
--
-
Shares outstanding
369,385,984
10 Years Aggregate
CFO
$-1,560.40 Mln
EBITDA
$-1,652.73 Mln
Net Profit
$-2,181.35 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Amyris (AMRS)
| -96.1 | 50.0 | -93.3 | -98.1 | -72.1 | -62.4 | -47.0 |
|
BSE Sensex*
| -11.1 | -2.1 | -8.9 | -7.5 | 6.6 | 9.1 | 11.4 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
Amyris (AMRS)
| -71.7 | -12.4 | 99.8 | -7.5 | -10.9 | -65.8 | -54.9 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Amyris (AMRS)
|
0.1 | 18.5 | 268.2 | -628.3 | -209.5 | -- | -- | 3.0 |
| 71.4 | 2,588.4 | 1,211.3 | -127.8 | -5.1 | -144.4 | -- | 67.6 | |
| 42.4 | 828.5 | 1,878.1 | 77.0 | 10.3 | 14.1 | 11.4 | 1.5 | |
| 7.3 | 846.8 | 1,879.4 | -133.8 | -4.3 | -17.3 | -- | 1.1 | |
| 1.4 | 68.2 | 11.2 | -2.7 | -10.0 | -- | -- | 7.9 | |
| 692.9 | 6,312.1 | 2,693.9 | 410.9 | 20.6 | 24 | 15.7 | 3.6 | |
| 27.7 | 3,237.0 | 6,719.6 | -127.0 | 0.9 | -6.8 | -- | 1.8 | |
| 1.2 | 7.2 | 18.9 | -249.7 | -335.4 | -112.8 | -- | 0.1 | |
| 142.6 | 2,489.1 | 1,926.2 | 4.3 | 4.0 | 0.3 | 530.9 | 1.9 | |
| 98.4 | 12,748.7 | 7,713.6 | 665.9 | 10.9 | 21.4 | 19.2 | 4.1 |
Shareholding Pattern
View DetailsAbout Amyris (AMRS)
Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and... wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. On August 9, 2023, Amyris, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Read more
-
Pres, CEO & Director
Mr. John G. Melo
-
Pres, CEO & Director
Mr. John G. Melo
-
Headquarters
EmeryVille, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Amyris (AMRS)
What is the current share price of Amyris Inc (AMRS) Today?
The share price of Amyris Inc (AMRS) is $0.06 (NASDAQ) as of 29-Sep-2023 09:30 EDT. Amyris Inc (AMRS) has given a return of -72.12% in the last 3 years.
What is the current PB & PE ratio of Amyris Inc (AMRS)?
Since, TTM earnings of Amyris Inc (AMRS) is negative, P/E ratio is not available.
The P/B ratio of Amyris Inc (AMRS) is 3.00 times as on 29-Sep-2023, a 0 discount to its peers’ median range of 3.01 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-0.97
|
-1.07
|
|
2021
|
-6.50
|
6.83
|
|
2020
|
-5.10
|
-9.62
|
|
2019
|
-1.73
|
-2.09
|
|
2018
|
-1.11
|
-1.18
|
What is the 52 Week High and Low of Amyris Inc (AMRS)?
The 52-week high and low of Amyris Inc (AMRS) are Rs -- and Rs -- as of 15-May-2026.
What is the market cap of Amyris Inc (AMRS)?
Amyris Inc (AMRS) has a market capitalisation of $ 18 Mln as on 29-Sep-2023. As per SEBI classification, it is a company.
Should I invest in Amyris Inc (AMRS)?
Before investing in Amyris Inc (AMRS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.